Loading…
for educational and safety purposes
IDRA-21 and Sunifiram both come up in the same conversations; they overlap on Glutamate. IDRA-21: IDRA-21 is a small synthetic molecule derived from the blood pressure drug diazoxide. Sunifiram: Sunifiram (DM-235) is a synthetic nootropic structurally related to piracetam but dramatically more potent, active at very low doses.
IDRA-21 is a small synthetic molecule derived from the blood pressure drug diazoxide. It does not switch brain receptors on by itself; instead it makes the AMPA receptor, which handles the brain's main fast excitatory signal, stay open longer once that natural signal arrives. Oral dosing improved memory scores in rats and in three separate monkey studies, which is why it is sold as a research chemical marketed for cognition. The evidence stops there; no person has ever been studied in a published trial, no clinical trial is registered, and no dose, blood level or side effect profile in humans has ever been reported. One rat study found it made hippocampal cell death after a stroke-like insult worse rather than better, so the safety picture is genuinely open.
Sunifiram (DM-235) is a synthetic nootropic structurally related to piracetam but dramatically more potent, active at very low doses. It enhances learning and memory by acting on the glycine site of the NMDA receptor and strengthening AMPA-mediated signaling through the CaMKII and PKC pathways, the molecular basis of long-term potentiation. In animal studies it improves cognition and reverses drug-induced amnesia at doses roughly a thousandfold lower than classic racetams, making it one of the most potent research nootropics of its kind.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
positive modulator
facilitates
facilitates
Mixed and modest. Inhibits currents evoked by exogenous GABA while slightly prolonging autaptic GABAergic currents; net direction depends on the preparation.
Binds within the LBD dimer interface and stabilises the agonist-bound dimer against dissociation. Hydrogen-bonds to Ser754, which underlies the partial selectivity of benzothiadiazides for the flip splice form.
boosts calcium
Negative modulator. Reduces whole-cell NMDA currents non-competitively and voltage-independently, shortens NMDA-mediated mEPSC decay, and is more effective at GluN1a/GluN2B than GluN1a/GluN2A. Effect is stronger at low glycine, suggesting interaction with the glycine site.
stimulates downstream
activates
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: Sunifiram is currently listed by more trusted vendors (2), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.